Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
For a rare and aggressive disease such as NUT carcinoma, experience matters. At Dana-Farber/Harvard Cancer Center (DF/HCC), our team of experienced NUT carcinoma specialists works together to provide patients with expert, compassionate, and comprehensive
Dr. Shapiro specializes in clinical trials for adult patients with NUT carcinoma.
Dr. Luo specializes in both standard of care and clinical trial options for adults with NUT carcinoma that originated, or is primarily located, in the lung or thoracic/chest cavity.
Dr. Hanna specializes in both standard of care and clinical trial options for adult patients with NUT carcinoma that originated, or is primarily located, in the head and neck region.
Dr. DuBois specializes in both standard of care and clinical trial options for pediatric patients with NUT carcinoma.
Our clinical team works closely with Brigham and Women's Hospital pathologist Christopher French, MD, who oversees the International NUT Midline Carcinoma Registry. Dr. French played
a pivotal role in the discovery of the NUT fusion oncogene. As a pathologist, Dr. French does not see patients; however, he is a leader in the field and is involved in much of the research surrounding NUT carcinoma. Dr. French is available for pathology
consultation to assist referring physicians with diagnosis.
New Patient Appointments
New Pediatric Patient Appointments
Clinical Trials Questions?
Dana-Farber Centers with NUT Carcinoma Specialists
Thoracic (Lung) Cancer Treatment CenterHead and Neck Cancer Treatment CenterChildhood Solid Tumor Center